In the paradigm of inflammation within obesity, it is hypothesized that IL-6 enhances the prevailing inflammation, thus precipitating insulin resistance and leading to further micro- and macrovascular complications (245). The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.